LEGN
Legend Biotech Corp
18.80$
+1.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.5% | -4.0% | +1.3% | -3.5% | -3.8% | -3.3% | +4.6% | +1.4% | +1.2% | -7.9% | +9.7% | |
| – | -0.7% | -5.6% | +0.8% | -5.2% | -4.9% | -5.1% | +2.6% | -0.6% | +0.4% | -13.2% | +13.4% | |
| – | +32.6% | -29.8% | -77.6% | +128.2% | -37.6% | +54.0% | -39.6% | +4.6% | +223.4% | -28.3% | +4.1% | |
| – | -8.1% | -0.5% | -0.8% | -6.1% | -7.4% | -10.4% | -3.8% | +2.6% | -4.4% | -12.0% | +15.6% | |
| – | +216.1% | -50.4% | +30.0% | +2.6% | +20.1% | +33.6% | +37.2% | -11.5% | +23.6% | -25.4% | +6.1% | |
| – | +7.9% | +14.0% | -14.8% | +24.8% | +1.5% | +29.4% | +15.1% | -18.0% | +9.6% | +15.9% | +11.9% | |
| – | -97.1% | +4,073.8% | -13.1% | +19.1% | -0.7% | +6.0% | +8.7% | +2.7% | -63.8% | -53.1% | +42.3% | |
| – | +19.5% | +2.3% | +4.6% | -3.0% | +1.6% | -5.0% | +9.4% | +7.2% | +4.3% | -14.0% | -17.1% | |
| – | +23.5% | +15.4% | +17.9% | -8.0% | +2.5% | -15.6% | +13.3% | +63.3% | +46.8% | -20.0% | -20.7% | |
| – | +8.9% | -1.9% | +6.7% | +30.6% | +10.4% | +11.4% | +10.6% | +2,444.0% | +117.3% | -15.1% | -39.3% | |
| – | +17.4% | +95.9% | +0.0% | -31.9% | +38.2% | +56.3% | +29.6% | +36.0% | -20.7% | -8.5% | +4.0% | |
| – | +2.0% | +1.8% | +1.8% | +1.7% | +1.5% | +1.5% | +1.5% | -44.6% | – | – | – | |
| – | -6.6% | -7.0% | -0.4% | -3.7% | -6.8% | -2.2% | +1.7% | -2.3% | -0.9% | -3.4% | +27.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.1% | +0.1% | +0.3% | +0.1% | +0.1% | +0.5% | +0.2% | +0.3% | +0.1% | +0.0% | +4.9% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.